The U.S. House has approved the FDA Modernization Act 2.0, which would end the animal testing requirement for new drugs and biosimilars. The bill doesn’t completely ban testing on animals but enables drug developers to use alternatives when feasible. In September, the U.S. Senate passed the FDA Modernization Act 2.0, S.5002. The new policy, known as the…